Modulation of UCP2 was recommended in diabetes complications [94], since the induction of UCP2 expression is safe: the function of the protein is further controlled at the posttranslational level and it also occurs as an endogenous protective mechanism. This evidence concerns the gene UCP2 and diabetes mellitus.